BCMA Has Moved Upstream—Managed Care Strategy Must Follow

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Optimizing Outcomes With Anti-CD38–Based Treatment for Smoldering and Newly Diagnosed Multiple Myeloma: Best Practices for Oncology Pharmacists #2 

Content Format:

Slideset

Credit Type:

--

Credits:

--
Optimizing Outcomes With Anti-CD38–Based Treatment for Smoldering and Newly Diagnosed Multiple Myeloma: Best Practices for Oncology Pharmacists

Content Format:

Slideset

Credit Type:

--

Credits:

--
Targeting BCMA in Early Relapsed/Refractory Myeloma: Translating New Clinical Evidence into Managed Care Strategies

Content Format:

Video

Credit Type:

ACPE

Credits:

1.50
Targeting BCMA in Early R/R Myeloma: Overview & CAR T-Cell Therapy

Content Format:

Slideset

Credit Type:

--

Credits:

--
Targeting BCMA in Early R/R Myeloma: Bispecific Antibodies and Antibody Drug Conjugates

Content Format:

Slideset

Credit Type:

--

Credits:

--
Targeting BCMA in Early R/R Myeloma: Considerations for Care Management

Content Format:

Slideset

Credit Type:

--

Credits:

--
BTK Inhibitors in CLL: Key Clinical Updates From ASCO & EHA 2025

Content Format:

Podcast

Credit Type:

--

Credits:

--
CLL Therapy Today: Answers to Your Latest Questions From the Experts

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Optimizing BTK Inhibitor Therapy in CLL: Updates and Strategies for Oncology Pharmacists

Content Format:

Video

Credit Type:

ACPE-P

Credits:

1.00
Optimizing BTK Inhibitor Therapy in CLL: Updates and Strategies for Oncology Pharmacists

Content Format:

Video

Credit Type:

ACPE-P

Credits:

1.00
Optimizing BTK Inhibitor Therapy in CLL: Updates and Strategies for Oncology Pharmacists

Content Format:

Slideset

Credit Type:

--

Credits:

--
Adverse Event Management, Adherence, and Drug–Drug Interactions With BTK Inhibitors

Content Format:

Slideset

Credit Type:

--

Credits:

--